Pages that link to "Q35907165"
Jump to navigation
Jump to search
The following pages link to Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNALys (Q35907165):
Displaying 27 items.
- Structure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1 (Q28319929) (← links)
- Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles (Q28646824) (← links)
- Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication (Q30651852) (← links)
- Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys) (Q35847385) (← links)
- Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription (Q35864780) (← links)
- In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription (Q35935052) (← links)
- Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. (Q36629265) (← links)
- Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1. (Q36637578) (← links)
- The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity (Q37532559) (← links)
- Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1. (Q38290548) (← links)
- Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication (Q38314018) (← links)
- Human immunodeficiency virus type-1 reverse transcriptase copies very short templates: Kinetic and crosslinking analysis (Q38319010) (← links)
- Phosphorodithioate DNA as a Potential Therapeutic Drug (Q38320951) (← links)
- Interaction of tRNA-derivatives and oligonucleotide primers with AZT-resistant mutants of HIV-1 reverse transcriptase. (Q38329680) (← links)
- Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNALys,3 (Q38336483) (← links)
- Inhibition of HIV-1 replication using a mutated tRNALys-3 primer (Q38345179) (← links)
- Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). (Q38362410) (← links)
- Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses (Q39594951) (← links)
- Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase (Q40115966) (← links)
- Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription (Q41125504) (← links)
- Cystatins in health and disease (Q41161690) (← links)
- Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes (Q45786901) (← links)
- Interaction of primer tRNA(Lys3) with the p51 subunit of human immunodeficiency virus type 1 reverse transcriptase: a possible role in enzyme activation (Q45789322) (← links)
- Interactions with tRNALysinduce important structural changes in human immunodeficiency virus reverse transcriptase (Q45859998) (← links)
- Biochemical characterization of the p51 sub‐unit of human immunodeficiency virus reverse transcriptase in homo‐ and heterodimeric recombinant forms of the enzyme (Q45881566) (← links)
- Initiation of in vitro reverse transcription from tRNA(Lys3) on HIV-1 or HIV-2 RNAs by both type 1 and 2 reverse transcriptases (Q47750003) (← links)
- DNA synthesis primed by mononucleotides (de novo synthesis) catalyzed by HIV-1 reverse transcriptase: tRNALys,3 activation (Q59084918) (← links)